AccurKardia’s AccurECG Named “Best New Technology Solution for ECG” in 9th Annual MedTech Breakthrough Awards Program
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies
NEW YORK–(BUSINESS WIRE)–AccurKardia, an innovator in ECG-based diagnostics technology, today announced that its AccurECGTM software platform has been selected as winner of the “Best New Technology Solution for ECG” award in the 9th annual MedTech Breakthrough Awards. The program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global digital health and medical technology market.
AccurECG(1) provides automated, near real-time beat-by-beat ECG analysis across multiple arrhythmias, including atrial fibrillation, atrial flutter, and other critical events. Device-agnostic and vendor neutral, the platform seamlessly integrates with diverse hardware including short duration recordings from ECG systems and multi-day Holter or patch monitors. AccurECG’s flexible API allows clinical and commercial partners to be swiftly integrated into existing workflows, reducing turnaround times and enhancing cardiac technicians’ capabilities in pinpointing dangerous cardiac arrhythmias and treating patients earlier.
